Status:
UNKNOWN
Treatment of Adenovirus Disseminated Infections in Hematopoietic Stem Cell Transplant Patients With Adenovirus Digestive Replication
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Patients Who Underwent Allograft
Eligibility:
All Genders
2-20 years
Brief Summary
Disseminated Adv infections are associated with high morbidity and mortality in HSCT pediatric patients. The most common source of Adv infection after pediatric HSCT is the host digestive tract where ...
Eligibility Criteria
Inclusion
- Allogeneic hematopoietic stem cell transplantation from any donor other than full-matched related donor
- Age above 2 months and under 20 years
- Provide written informed consent from the parents (if \<18) and child
- Free, informed and written consent, signed by the patient and investigator before any Study examination. If the patient is a minor by child (if possible) and both parents or child and the legal representative in case only one parent is alive
Exclusion
- Hematopoietic stem cell transplantation from full-matched related donor
- Females who are pregnant or currently nursing
- Any patient receiving cidofovir, ribavirin or any other anti-viral drug under development given in order to treat or prevent
- Current disease attributed to adenovirus infection
- Lack of affiliation to a social security scheme (as a beneficiary or assignee).Current disease attributed to adenovirus infection
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03481244
Start Date
April 1 2020
End Date
December 1 2023
Last Update
February 10 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.